Drug profile · INN
fulvestrant
FASLODEX
- US status
- approved
- Patents linked
- 0
- News articles
- 0
Quick answer
fulvestrant (FASLODEX) is an FDA-listed pharmaceutical active ingredient. Associated with Amneal Pharma Europe Ltd. Route of administration: intramuscular. Current US regulatory status: approved.
Key facts
INN fulvestrant
Brand FASLODEX
Route INTRAMUSCULAR
Formulation SOLUTION
ATC code L02BA03
Originator Amneal Pharma Europe Ltd
Frequently asked questions
What is fulvestrant?
fulvestrant (FASLODEX) is an FDA-listed pharmaceutical active ingredient. Associated with Amneal Pharma Europe Ltd. Route of administration: intramuscular. Current US regulatory status: approved.
What is the brand name for fulvestrant?
FASLODEX is a marketed brand name for fulvestrant. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of fulvestrant?
fulvestrant has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.